Latest Trials
| EudraCT Number: 2006-002037-20 | Sponsor Protocol Number: GA/9016 | Start Date: 2006-07-27 | |||||||||||
| Sponsor Name: Teva Pharmaceutical Industries, Ltd. | |||||||||||||
| Full Title: A multi-national, multi-centre, randomized, parallel-group, double-blind study to compare the efficacy, tolerability and safety of Glatiramer Acetate Injection 40 mg/ml to that of Glatiramer Acetat... | |||||||||||||
| Medical condition: Relapsing-remitting Multiple Sclerosis (RR MS) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Prematurely Ended) FI (Prematurely Ended) ES (Prematurely Ended) BE (Completed) GB (Prematurely Ended) LV (Prematurely Ended) CZ (Prematurely Ended) IT (Prematurely Ended) LT (Prematurely Ended) DE (Prematurely Ended) EE (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||